Fagforeningen Pharmadanmark company information, Employees & Contact Information

Zealand Pharma A/S' (CPH:ZEAL) Share Price Boosted 26% But Its Business Prospects Need A Lift Too simplywall.st

'Gross disappointment': Danish pharma giant Novo Nordisk cuts earning forecasts The Local Denmark

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) Via Ritzau

Look at ‘forgotten’ pharma stocks to hedge the weight-loss war Investors' Chronicle

Analysts Are Updating Their Zealand Pharma A/S (CPH:ZEAL) Estimates After Its First-Quarter Results simplywall.st

LEO Pharma presents two late-breaking abstracts for temtokibart reporting positive Phase 2b efficacy, safety and biomarker results in moderate-to-severe atopic dermatitis at the 2025 EADV Annual Meeting in Paris Via Ritzau

Palghar Tragedy: Four Workers Died in Gas Leak Incident at Pharma Company in Boisar lokmattimes.com

Institutional owners may take dramatic actions as Zealand Pharma A/S' (CPH:ZEAL) recent 5.2% drop adds to one-year losses simplywall.st

Boehringer Ingelheim and LEO Pharma enter partnership to commercialize and further develop SPEVIGO® (spesolimab) Via Ritzau

Zealand Pharma A/S (CPH:ZEAL) Could Be Less Than A Year Away From Profitability simplywall.st

Zealand Pharma Via Ritzau

LEO Pharma closes deal for Spevigo® Via Ritzau

Most Shareholders Will Probably Find That The CEO Compensation For Zealand Pharma A/S (CPH:ZEAL) Is Reasonable simplywall.st

Zealand Pharma A/S (CPH:ZEAL) Analysts Are Way More Bearish Than They Used To Be simplywall.st

LEO Pharma Initiates Phase 2a DELTA NEXT Trial of Delgocitinib Cream in Adults with Mild to Severe Palmoplantar Pustulosis (PPP) Via Ritzau

Zealand Pharma Via Ritzau

Zealand Pharma Via Ritzau

Liisa Hurme and Mark Levick elected to LEO Pharma’s Board of Directors Via Ritzau

GILEAD AND LEO PHARMA ENTER INTO STRATEGIC PARTNERSHIP TO ACCELERATE DEVELOPMENT OF ORAL STAT6 PROGRAM WITH POTENTIAL IN MULTIPLE INFLAMMATORY DISEASES Via Ritzau

Strides Pharma Consolidates European Business-to-Business Operations in Switzerland Via Ritzau

Zealand Pharma Announces Global License and Development GlobeNewswire

OBI Pharma Inc. Via Ritzau

LEO Pharma delivers double-digit revenue growth and strong progress for strategic transformation Via Ritzau

To sharpen focus on the global commercialization of strategic products and the external partnership model, LEO Pharma makes changes to leadership Via Ritzau

Zealand Pharma Via Ritzau

LEO Pharma commits to net-zero greenhouse gas emissions by 2050 Via Ritzau

Junshi Biosciences Via Ritzau

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain Via Ritzau

IPO-aktuella DanCann Pharma utvecklar medicinsk cannabis med NASA-teknik Biostock

LEO Pharma Receives Positive CHMP Opinion for New Adtralza® (tralokinumab) Injection Device Via Ritzau

LEO Pharma provides update on the development program for izuforant Via Ritzau

LEO Pharma A/S appoints Brian Hilberdink new President of LEO Pharma Inc. United States Via Ritzau

LEO Pharma announces positive phase 3 head-to-head data results from DELTA FORCE trial comparing delgocitinib cream with alitretinoin capsules in adults with severe chronic hand eczema (CHE) Via Ritzau

The LEO Foundation announces closing of Nordic Capital’s investment in LEO Pharma Via Ritzau

Watch: Massive fire guts pharma cold storage unit in Annaram, no casualties reported Telangana Today

EVER-PHARMA Via Ritzau

Health Tech & Pharma Delegation to Riyadh, Saudi Arabia Dansk Industri

New Danish alliance will combat a global health crisis Novo Nordisk Fonden

New General Manager appointed to lead LEO Pharma across the Nordic region Via Ritzau

LEO Pharma delivers 9% revenue growth at constant exchange rates and doubles adjusted EBITDA margin to 16% Via Ritzau

Zealand Pharma Via Ritzau

DK Pharma follows JMJ SC to the Super Division – A story of two unique sides Football Counter

AshCure Pharma and 1Point Pharma sign agreement to deliver pharmaceuticals to the Nordics Via Ritzau

DK Pharma FC to conduct open trials for the upcoming season Football Counter